RCAL
CORZ icon

Rose Capital Advisors LLC’s Core Scientific CORZ Stock Holding History

Rose Capital Advisors LLC’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
+12,680
New +$299K 0.16% 79

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CCAM
Capelight Capital Asset Management New York $208M AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Rose Capital Advisors LLC's CORZ Position: Q2 2026 in Review

Rose Capital Advisors LLC opened a new position in Core Scientific (CORZ) in Q2 2026: 12,680 shares worth $324K. The stake represents 0.16% of the portfolio and ranks #79 among its holdings.

153 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Rose Capital Advisors LLC held 12,680 shares of Core Scientific worth $324K as of Q2 2026.
  • Core Scientific was a new Rose Capital Advisors LLC position in Q2 2026.
  • Core Scientific made up 0.16% of Rose Capital Advisors LLC's portfolio in Q2 2026, its #79 holding.
  • 153 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Rose Capital Advisors LLC's 13F filing for Q2 2026, filed 7 Aug 2026.